United States Food Allergy Market Trends to Reach USD 3,429.3 Million by 2033, North America Holds 38% Share, ALK-Abelló, bioMérieux & Astellas Pharma Lead

DataM Intelligence has released a new research report titled "Food Allergy Market Size 2026." The report delivers in-depth insights into key market dynamics, including regional growth trends, market segmentation, CAGR projections, and the revenue performance of leading industry players. It also highlights major growth drivers shaping the market landscape. Designed to provide a clear and comprehensive perspective, the report offers a detailed view of the current market size in terms of both value and volume, along with emerging opportunities and the overall development outlook of the global Food Allergy market.

Download Free Sample Report (Get Higher Priority for Corporate Email ID):-
https://www.datamintelligence.com/download-sample/food-allergy-market?sindhuri

Strategic Insights
• The rising global prevalence of food allergies is accelerating demand for advanced diagnostics, treatment options, and allergen-free food products. In the U.S. alone, around 33 million people are affected by food allergies, with millions of emergency visits linked to severe allergic reactions each year.
• Regulatory focus on allergen transparency and early allergy prevention is reshaping the market. Measures such as mandatory allergen labeling, the inclusion of sesame under major allergen regulations, and growing adoption of component-resolved diagnostics (CRD) are supporting better diagnosis, patient-specific management, and safer food consumption practices.

United States: Recent Industry Developments
✅ May 2026: DBV Technologies reported positive Phase 3 VITESSE trial results for Viaskin Peanut, strengthening the U.S. pipeline for non-invasive pediatric peanut allergy immunotherapy.
✅ February 2026: Aquestive Therapeutics received a U.S. FDA Complete Response Letter for ANAPHYLM, its sublingual epinephrine film, and moved ahead with additional usability studies for needle-free emergency allergy treatment.
✅ January 2026: Novartis advanced development plans for remibrutinib and broadened biologic treatment strategies targeting severe allergic diseases, including food allergy management.
✅ January 2026: GlaxoSmithKline announced the acquisition of RAPT Therapeutics to strengthen its long-acting IgE-targeting therapy pipeline for severe food allergy treatment.
✅ 2025: Nestlé Health Science continued commercialization and market expansion of PALFORZIA in the U.S., supporting broader adoption of oral immunotherapy for peanut allergy management.

List of Key Players 2026:
Astellas Pharma, ALK-Abelló, bioMérieux, Omega Diagnostics Group, HYCOR Biomedical and Cambridge Allergy. DataM Intelligence also lists Aimmune Therapeutics, Meridian Medical Technologies, Medeca Pharma AB and HOB Biotech Group among the major global participants in the market.

Company Evaluation
Established allergy and diagnostics-focused companies such as ALK-Abelló and bioMérieux are positioned to benefit from rising demand for allergy testing, immunotherapy and hospital-based allergy management solutions. Their strengths lie in established clinical networks, regulatory familiarity and broader diagnostic or therapeutic portfolios.

Specialty food-allergy innovators such as Aimmune Therapeutics and Cambridge Allergy are gaining attention for oral immunotherapy, biologics and precision allergy management approaches. At the same time, investors should closely evaluate commercialization scale, regulatory progress, payer adoption and long-term treatment adherence, since these factors will strongly influence market success. The market is also being supported by stricter allergen-labeling regulations, rising consumer awareness and increasing use of advanced diagnostic methods such as component-resolved diagnostics.

Growth Forecast Projected 2026:
The Global food allergy market is projected to grow from USD 2,394.9 million in 2025 to USD 3,429.3 million by 2033, registering a CAGR of 4.59% during the forecast period (2025-2033). Growth is being driven by the increasing prevalence of food allergies, expanding awareness of severe allergic reactions, stronger allergen-labeling regulations and ongoing innovation in diagnostics, immunotherapy and biologic treatment options.

Key Developments 2025-2026:
✅ April 2026: Food manufacturers accelerated the launch of allergen-free and clean-label food products, expanding options for consumers with food allergies and dietary sensitivities.
✅ March 2026: Healthcare providers and diagnostic companies increased investments in advanced molecular diagnostics and precision allergy testing to improve early detection and personalized treatment strategies.
✅ February 2026: Regulatory authorities strengthened food allergen labeling requirements and traceability standards to enhance consumer safety and reduce accidental allergen exposure.
✅ January 2026: Biotechnology companies advanced the development of innovative immunotherapies and oral desensitization treatments aimed at reducing the severity of food allergies and improving long-term patient outcomes.
✅ December 2025: Digital health companies expanded AI-enabled allergy management platforms, enabling real-time allergen tracking, personalized nutrition guidance, and remote patient monitoring.
✅ November 2025: Research institutions and pharmaceutical companies strengthened collaborations to accelerate clinical trials for next-generation food allergy therapeutics, including biologics and precision medicine approaches.
✅ October 2025: Food service providers and packaged food manufacturers expanded allergen management programs, improving cross-contamination controls, ingredient transparency, and consumer education initiatives.

Request Strategic Market Customization:
https://www.datamintelligence.com/customize/food-allergy-market?sindhuri

How Our Market Research Process Works:
The global Food Allergy Market research report is developed using a comprehensive combination of primary and secondary data sources. The study evaluates a wide range of industry-influencing factors, including regulatory frameworks, evolving consumer awareness, healthcare trends, competitive landscape, and historical market performance. It also analyzes advancements in allergy diagnostics, immunotherapy, biologics, digital health technologies, and innovations in allergen-free food products. In addition, the report assesses market dynamics, investment trends, emerging opportunities, potential barriers, and key challenges that could influence the future growth of the global Food Allergy Market.

Recent Mergers & Acquisitions (M & A) 2025-2026:
• April 2026: A leading specialty nutrition company expanded its allergen-free foods portfolio through the acquisition of a clean-label snack manufacturer focused on peanut-free and dairy-free formulations.
• March 2026: A global diagnostics player strengthened its food allergy testing business by acquiring an allergy-focused diagnostic platform with capabilities in component-resolved diagnostics (CRD) and precision allergy profiling.
• February 2026: A pediatric immunology-focused biotech entered a strategic acquisition agreement to broaden its pipeline of oral immunotherapy and biologic solutions for food allergy management.
• January 2026: A consumer health and food safety company acquired an allergen-testing solutions provider to enhance rapid detection, food labeling compliance, and traceability capabilities across packaged food supply chains.

Japan: Recent Industry Developments
✅ March 2026: Astellas Pharma Inc. expanded research initiatives in immune-modulation and pediatric allergy management to support next-generation food allergy treatment development.
✅ February 2026: Thermo Fisher Scientific Japan strengthened advanced allergy diagnostics offerings in Japan, supporting improved food allergen detection and precision testing adoption.
✅ January 2026: Meiji Holdings Co., Ltd. increased focus on hypoallergenic and allergen-conscious nutrition products aligned with rising consumer demand for safer food options.
✅ December 2025: Morinaga Milk Industry Co., Ltd. expanded development of allergy-friendly nutritional formulations and infant food solutions aimed at supporting food-sensitive populations.

Buy Now & Unlock 360° Market Intelligence:
https://www.datamintelligence.com/buy-now-page?report=food-allergy-market?sindhuri

Segments Covered in the Global Food Allergy Market:
By Food Source
The market is segmented into peanuts (26%), milk (21%), eggs (16%), tree nuts (14%), seafood (11%), wheat (7%), and others (5%). Peanuts dominate the market due to their high prevalence as one of the leading causes of severe allergic reactions and anaphylaxis worldwide, driving demand for diagnostics, emergency treatments, and allergen management products. Milk and egg allergies are highly common among infants and children, supporting continuous demand for specialized nutritional products and clinical care. Tree nuts, seafood, and wheat allergies continue to increase globally due to changing dietary patterns and improved diagnosis, while other food allergens contribute to niche but growing segments.

By Diagnosis
The market is segmented into skin prick tests (38%), blood tests (31%), oral food challenge (18%), and others (13%). Skin prick tests lead the market due to their rapid results, cost-effectiveness, and widespread use as the first-line diagnostic method for identifying food allergies. Blood tests are extensively utilized for patients who cannot undergo skin testing and for measuring allergen-specific IgE antibodies. Oral food challenges remain the gold standard for confirming food allergies despite requiring specialized clinical supervision, while other diagnostic methods support specific and emerging testing requirements.

By Treatment
The market is segmented into epinephrine (41%), antihistamines (27%), oral immunotherapy (22%), and others (10%). Epinephrine dominates the market as it is the primary emergency treatment for severe allergic reactions and anaphylaxis, with increasing availability of auto-injectors globally. Antihistamines are widely used to manage mild to moderate allergic symptoms, while oral immunotherapy is gaining significant traction as an emerging long-term treatment approach aimed at reducing allergic sensitivity. Other treatment options include corticosteroids and supportive therapies for symptom management.

By Distribution Channel
The market is segmented into hospital pharmacies (36%), retail pharmacies (34%), online pharmacies (20%), and others (10%). Hospital pharmacies account for the largest share due to the high volume of prescription-based allergy medications and emergency treatments dispensed through healthcare facilities. Retail pharmacies maintain strong demand owing to widespread accessibility of allergy medications and epinephrine auto-injectors. Online pharmacies are witnessing rapid growth driven by increasing digital healthcare adoption, home delivery services, and greater patient convenience, while other distribution channels cater to specialty clinics and institutional procurement.

By Region
North America - 38% Share
North America leads the market due to the high prevalence of food allergies, advanced healthcare infrastructure, widespread awareness, favorable reimbursement policies, and strong adoption of innovative diagnostic and treatment solutions across the United States and Canada.

Europe - 26% Share
Europe is driven by growing food allergy prevalence, strong regulatory support for food allergen labeling, increasing adoption of advanced diagnostic technologies, and rising investments in immunotherapy across Germany, France, the UK, Italy, and Spain.

Asia Pacific - 22% Share
Asia Pacific is expanding rapidly due to rising healthcare expenditure, increasing diagnosis rates, changing dietary habits, growing pediatric population, and improving access to allergy care across China, Japan, India, South Korea, and Australia.

Contact:
Fabian
DataM Intelligence 4market Research LLP 6th Floor, M2 Tech Hub, DataM Intelligence 4market Research LLP, Lalitha Nagar, Habsiguda,
Secunderabad, Hyderabad, Telangana 500039
Email: fabian@datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology. Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.